Australian women at high risk of ovarian cancer will participate in a study of a new screening test developed by Melbourne scientists, a report said.
About 300 Victorian and South Australian women carrying the BRCA1 or BRCA2 genes will be recruited for the study, News Corp Australia reports.
Andrew Stephens of the Hudson Institute of Medical Research is optimistic that his screening test, the Active Ratio Test, will help discover the cancer.  Melbourne scientists are developing a new screening test for ovarian cancer in high-risk women. "class =" JsEnabled_Op (0) JsEnabled_Bg (n) Trsdu (.42s) Bgr (nr) Bgz (cv) StretchedBox W (100%) H (100%) ie-7_H (a) "itemprop =" url "style = "background-image: url (https://s.yimg.com/ny/api/res/1.2/2jBkLjPA2wwE_KsPzO6O8Q–~A/YXBwaWQ9aGlnaGxhbmRlcjtzbT0xO3c9ODAw/http://media.zenfs.com/en/homerun/feed_manager_auto_publish_494/a91b9f016a09bc52da9d2ed682130141 ); src = "https://s.yimg.com/g/images/spaceball.gif" data-reactid = "22" />
Melbourne scientists have developed a new screening test for ovarian cancer Source: Getty Images / File
"Ultimately, we hope to detect pre-cancerous lesions, just as Pap smears early changes in Cervical cancer can be detected, "said Dr. Stephens the Herald Sun.
" First, we would like to determine if it is used as a screening tool to monitor women could be used at high risk to let them know if they need prophylactic surgery.
"Ideally, we want the test to be part of a routine screening program for women."
The Ovarian Cancer Research Foundation will announce on Monday that it will contribute nearly $ 900,000 to the trial.